Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX: DLIDelta Lithium LimitedMaterials

Delta Lithium Mt Ida Scoping Study Models $748M NPV

Delta Lithium's Mt Ida Scoping Study models a post-tax NPV of $748M and IRR of 33% on $483M pre-production capital, at +/- 40% accuracy with funding needed.

By Digifin Pty Ltd · About this coverage

Key Points

  • Scoping Study models post-tax NPV of $748M at an 8% discount rate and IRR of 33%
  • Pre-production capital of $483M with a payback period of 4.3 years
  • 1Mtpa concentrator producing spodumene, lepidolite and tantalum concentrates
  • Study accuracy of +/- 40%; further funding will likely be required
Delta Lithium Limited (ASX:DLI)

About Delta Lithium (ASX:DLI)

Delta Lithium Limited is an ASX-listed lithium exploration and development company headquartered in Perth. It owns the Mt Ida lithium project in Western Australia's Eastern Goldfields and holds other lithium exploration projects in the state.

Delta Lithium (ASX:DLI) released a Scoping Study for its 100% owned Mt Ida Lithium Project in Western Australia, setting out a first potential development case for lithium, tantalum and rubidium.

The study assumes a 1Mtpa Whole Ore Flotation lithium concentrator onsite, producing spodumene concentrate (SC5.5%), lepidolite concentrate (LC3.0% Li2O, 1.8% Rb2O) and tantalum concentrate. Mining starts with open pits at Sister Sam and Timoni before moving underground. Over an 11-year life of mine including construction, the study models 8.5 Mt processed, producing 640kt of spodumene concentrate, 1,080kt of lepidolite concentrate and 17kt of tantalum concentrate, at an overall lithium recovery of approximately 73%. Post-tax outcomes, in real 2026 Australian dollars, are free cash flow of $1,415M, NPV of $748M at an 8% discount rate, IRR of 33% and a payback period of 4.3 years, against pre-production capital of $483M. Long-term lithium price forecasts were sourced from Benchmark Minerals Intelligence. The study rests on a Mineral Resource Estimate of 14.8 Mt @ 1.21% Li2O, with 73% Measured and Indicated Resources. The company states Mt Ida is fully permitted for open pit and underground mining.

The study is accurate to +/- 40% and cannot support Ore Reserves, and the production target includes Inferred material. Delta says further funding will likely be required and may be dilutive, and it could pursue a sale or joint venture.

Back to all ASX Company News

Source: Delta Lithium Limited (ASX:DLI), 17 November 2026. Summary content supplied by Digifin Pty Ltd.

News summary only, not financial advice. It does not consider your objectives, financial situation or needs.

Tuesday, 17 November 2026

Also summarised today

All ASX Company News
ASX: 29MMaterials

29Metals Wins Preliminary Capricorn Copper Tailings Approval

29Metals received preliminary approval for a new tailings facility at Capricorn Copper, a key restart step, while EPBC approval and restart funding remain open.

17 Nov, 8:25 am AEDT
ASX: CATInformation Technology

Catapult 1H FY27 ACV Up 25% to US$145.2M, Margin at 20%

Catapult's 1H FY27 Annualized Contract Value rose 25% (CC) to US$145.2M and Management EBITDA reached US$16.1M at a 20% margin, with no numerical FY27 guidance.

17 Nov, 8:40 am AEDT
ASX: LRVMaterials

Larvotto Ships First Hillgrove Gold Concentrate to Glencore

Larvotto despatched its first gold concentrate from Hillgrove to offtake partner Glencore, after antimony in October, with first gold doré due in late November.

17 Nov, 9:34 am AEDT
ASX: LYLIndustrials

Lycopodium Wins A$31.1m Assafou Construction Management Role

Lycopodium won a construction management contract worth about A$31.1 million at Endeavour Mining's Assafou project, taking total work there to A$74.0 million.

17 Nov, 8:31 am AEDT
ASX: MEZUtilities

Meridian Hydro Storage at 128% as Retail Volumes Fall 8.3%

Meridian Energy's October 2026 report shows national hydro storage at 128% of average by 9 November, while retail sales volumes fell 8.3% on October 2025.

17 Nov, 7:30 am AEDT
ASX: MYXHealth Care

Mayne Pharma Agrees A$6.40 Cash Scheme With Gedeon Richter

Mayne Pharma entered a scheme deed for Gedeon Richter to acquire it at A$6.40 cash per share, valuing equity at about A$604 million, subject to approvals.

17 Nov, 9:13 am AEDT
ASX: PDIMaterials

PDI Gold Granted Bankan and Mansounia Exploitation Permits

Guinea granted PDI Gold Exploitation Permits for Bankan and Mansounia, with Bankan's first gold expected in mid-2028 and no rise to US$463m capital expected.

17 Nov, 9:26 am AEDT
ASX: PRNMaterials

Perenti Wins Circa A$1 Billion Geita Underground Contract

Perenti's AUMS won a new five-year underground mining contract at AngloGold Ashanti's Geita Gold Mine in Tanzania with an estimated value of about A$1 billion.

17 Nov, 8:56 am AEDT
ASX: TNEInformation Technology

TechnologyOne FY26 Profit Before Tax Up 20% to $217.6m

TechnologyOne's FY26 profit before tax rose 20% to $217.6 million, top of upgraded guidance, with ARR up 18% to $652.1 million and a 32.5c final dividend.

17 Nov, 8:58 am AEDT

Announcement summaries are published each trading day. General advice only.

Copyright © 2026 SureStone Capital